View Older Stories View More Recent Stories
-
Zentek Ltd. Regains Nasdaq Compliance re Minimum Bid Price
-
ZenGUARD(TM) Enhanced Air Filters to Be Added as Class 1 Medical Device Under Zentek's Medical Device Establishment Licence
-
Zentek (ZTEK) and Triera Biosciences Ltd. Receive $1.1 Million Government of Canada Contract to Test Multivalent Aptamer Technology
-
Zentek and Triera Biosciences Ltd. Receive $1.1 Million Government of Canada Contract to Test Multivalent Aptamer Technology
-
Zentek (ZTEK) Provides Regulatory Update for ZenGUARD Enhanced Air Filters
-
Zentek Provides Regulatory Update for ZenGUARD(TM) Enhanced Air Filters
-
Zentek (ZTEK) Provides Market Update on ZenGUARD Antimicrobial Surgical Masks
-
Zentek Provides Market Update on ZenGUARD(TM) Antimicrobial Surgical Masks
-
Zentek Announces Voting Results of Annual and Special Meeting
-
Zentek (ZTEK) Receives Nasdaq Non-compliance Notice
-
Zentek Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
Zentek Announces Closing of Non-Brokered Private Placement of Units
-
Zentek (ZTEK) Announces Upsized Private Placement of Units
-
Zentek Announces Upsize to Non-Brokered Private Placement of Units
-
Zentek Announces Normal Course Issuer Bid
-
Zentek Announces Preliminary Battery Results and University of Toronto Receives NSERC Mission Alliance Grant to Optimize Graphite for Battery Anode Use
-
Zentek Launches National Sampling Program for ZenGUARD(TM) Antimicrobial Surgical Masks
-
Zentek (ZTEK) Announces 2.3M Unit Placement at $1.30/sh
-
Zentek Announces Non-Brokered Private Placement of Units for up to $3 Million
-
Zentek Subsidiary Albany Graphite Corp. Achieves Five Nines Purity for Albany Graphite
-
Zentek Announces Grant of Stock Options
